These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23404464)

  • 1. Competitive binding sites of a ruthenium arene anticancer complex on oligonucleotides studied by mass spectrometry: ladder-sequencing versus top-down.
    Wu K; Hu W; Luo Q; Li X; Xiong S; Sadler PJ; Wang F
    J Am Soc Mass Spectrom; 2013 Mar; 24(3):410-20. PubMed ID: 23404464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and discrimination of binding sites of an organoruthenium anticancer complex to single-stranded oligonucleotides by mass spectrometry.
    Liu S; Wu K; Zheng W; Zhao Y; Luo Q; Xiong S; Wang F
    Analyst; 2014 Sep; 139(18):4491-6. PubMed ID: 25028701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymines in single-stranded oligonucleotides and G-quadruplex DNA are competitive with guanines for binding to an organoruthenium anticancer complex.
    Wu K; Liu S; Luo Q; Hu W; Li X; Wang F; Zheng R; Cui J; Sadler PJ; Xiang J; Shi Q; Xiong S
    Inorg Chem; 2013 Oct; 52(19):11332-42. PubMed ID: 24024654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of interstrand migration of organoruthenium anticancer complexes within a DNA duplex.
    Wu K; Luo Q; Hu W; Li X; Wang F; Xiong S; Sadler PJ
    Metallomics; 2012 Feb; 4(2):139-48. PubMed ID: 22262368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competition between glutathione and DNA oligonucleotides for ruthenium(II) arene anticancer complexes.
    Wang F; Xu J; Wu K; Weidt SK; Mackay CL; Langridge-Smith PR; Sadler PJ
    Dalton Trans; 2013 Mar; 42(9):3188-95. PubMed ID: 23076358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of Organometallic Ruthenium Anticancer Complexes to DNA: Thermodynamic Base and Sequence Selectivity.
    Liu S; Liang A; Wu K; Zeng W; Luo Q; Wang F
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30041439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.
    Chen H; Parkinson JA; Parsons S; Coxall RA; Gould RO; Sadler PJ
    J Am Chem Soc; 2002 Mar; 124(12):3064-82. PubMed ID: 11902898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms.
    Chen H; Parkinson JA; Morris RE; Sadler PJ
    J Am Chem Soc; 2003 Jan; 125(1):173-86. PubMed ID: 12515520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the binding site of ruthenium complexes to short single-stranded oligodeoxynucleotides using electrospray ionization tandem mass spectrometry.
    Starke I; Fürstenberg S
    Rapid Commun Mass Spectrom; 2022 Feb; 36(4):e9231. PubMed ID: 34866265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective binding of an organoruthenium complex to G-rich human telomeric sequence by tandem mass spectrometry.
    Cheng Y; Zeng W; Cheng Y; Zhang J; Zou T; Wu K; Wang F
    Rapid Commun Mass Spectrom; 2018 Dec; 32(24):2152-2158. PubMed ID: 30252980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruthenium versus platinum: interactions of anticancer metallodrugs with duplex oligonucleotides characterised by electrospray ionisation mass spectrometry.
    Groessl M; Tsybin YO; Hartinger CG; Keppler BK; Dyson PJ
    J Biol Inorg Chem; 2010 Jun; 15(5):677-88. PubMed ID: 20213306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of an organo-osmium(II) anticancer complex to guanine and cytosine on DNA revealed by electron-based dissociations in high resolution Top-Down FT-ICR mass spectrometry.
    Wootton CA; Sanchez-Cano C; Liu HK; Barrow MP; Sadler PJ; O'Connor PB
    Dalton Trans; 2015 Feb; 44(8):3624-32. PubMed ID: 25650025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metal complexes as DNA intercalators.
    Liu HK; Sadler PJ
    Acc Chem Res; 2011 May; 44(5):349-59. PubMed ID: 21446672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study on the interactions of human copper chaperone Cox17 with anticancer organoruthenium(II) complexes and cisplatin by mass spectrometry.
    Li L; Guo W; Wu K; Wu X; Zhao L; Zhao Y; Luo Q; Wang Y; Liu Y; Zhang Q; Wang F
    J Inorg Biochem; 2016 Aug; 161():99-106. PubMed ID: 27235272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.
    Novakova O; Chen H; Vrana O; Rodger A; Sadler PJ; Brabec V
    Biochemistry; 2003 Oct; 42(39):11544-54. PubMed ID: 14516206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA structural distortions induced by ruthenium-arene anticancer compounds.
    Gossens C; Tavernelli I; Rothlisberger U
    J Am Chem Soc; 2008 Aug; 130(33):10921-8. PubMed ID: 18651736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Head-to-head" double-hamburger-like structure of di-ruthenated d(GpG) adducts of mono-functional Ru-arene anticancer complexes.
    Liu HK; Kostrhunova H; Habtemariam A; Kong Y; Deeth RJ; Brabec V; Sadler PJ
    Dalton Trans; 2016 Nov; 45(46):18676-18688. PubMed ID: 27830851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photo-induced DNA cleavage and cytotoxicity of a ruthenium(II) arene anticancer complex.
    Brabec V; Pracharova J; Stepankova J; Sadler PJ; Kasparkova J
    J Inorg Biochem; 2016 Jul; 160():149-55. PubMed ID: 26778426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive and negative nano-electrospray mass spectrometry of ruthenated serum albumin supported by docking studies: an integrated approach towards defining metallodrug binding sites on proteins.
    Nišavić M; Janjić GV; Hozić A; Petković M; Milčić MK; Vujčić Z; Cindrić M
    Metallomics; 2018 Apr; 10(4):587-594. PubMed ID: 29561550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cancer cell growth by ruthenium(II) arene complexes.
    Morris RE; Aird RE; Murdoch Pdel S; Chen H; Cummings J; Hughes ND; Parsons S; Parkin A; Boyd G; Jodrell DI; Sadler PJ
    J Med Chem; 2001 Oct; 44(22):3616-21. PubMed ID: 11606126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.